Apyx Medical (APYX)
(Real Time Quote from BATS)
$1.12 USD
+0.06 (5.66%)
Updated Aug 13, 2024 01:30 PM ET
2-Buy of 5 2
C Value D Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
APYX 1.12 +0.06(5.66%)
Will APYX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APYX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APYX
Apyx Medical (APYX) Reports Q2 Loss, Lags Revenue Estimates
Ayr Wellness Inc. (AYRWF) Reports Q2 Loss, Lags Revenue Estimates
APYX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Lags Revenue Estimates
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
Other News for APYX
Renuvion Named #1 Trusted Body Contouring Technology by Doctors*
Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript
Apyx Medical price target lowered by $2 at Craig-Hallum, here's why
Lake Street Sticks to Its Buy Rating for Apyx Medical (APYX)
Apyx Medical (APYX) Receives a Hold from Piper Sandler